On Apr. 23, 2020, Daxor Corp. announced that the U.S. Department of Defense (DOD) had awarded the Company a $1.1 million contract for the development and deployment of a small, portable, highly accurate, battery-powered Blood Volume Analyzer.

Once the Company moves into mass-manufacturing the advanced device, both parties agreed that the technology is also suitable for civilian use in hospitals and outpatient settings.